arginine has been researched along with n(6)-carboxymethyllysine in 130 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 30 (23.08) | 18.2507 |
2000's | 51 (39.23) | 29.6817 |
2010's | 44 (33.85) | 24.3611 |
2020's | 5 (3.85) | 2.80 |
Authors | Studies |
---|---|
Höger, H; Lubec, B; Lubec, G; Szalay, S; Weninger, M; Xi, Z | 1 |
Sakurai, T; Takanashi, M; Tsuchiya, S | 1 |
Bailie, KE; Baynes, JW; Dunn, JA; Dyer, DG; Lyons, TJ | 1 |
Baynes, JW; Dunn, JA; Dyer, DG; Lyons, TJ; Silvestri, G | 1 |
Baynes, JW; Thorpe, SR; Wells-Knecht, MC | 1 |
Baynes, JW; Bell-Farrow, AD; Cefalu, WT; Fu, MX; Sonntag, WE; Thorpe, SR; Wang, ZQ | 1 |
Khaidar, A; Lubec, B; Lubec, G; Marx, M | 1 |
Höger, H; Lubec, B; Lubec, G; Radner, W; Salzer, H | 1 |
Baynes, JW; Blackledge, JA; Fu, MX; Lyons, TJ; Thorpe, SR; Wells-Knecht, KJ | 1 |
Bailie, KE; Baynes, JW; Dunn, JA; Dyer, DG; Lyons, TJ; McCance, DR; Thorpe, SR | 1 |
Horiuchi, S; Ikeda, K; Kimura, T; Miyakawa, T; Miyata, T; Sobue, G; Takamatsu, J | 1 |
Bailey, AJ; Paul, RG | 1 |
Ahmed, MU; Baynes, JW; Brinkmann, E; Litchfield, JE; Reddy, S; Thorpe, SR; Wells-Knecht, KJ; Wells-Knecht, MC; Zyzak, DV | 1 |
Cai, Z; Horie, K; Iida, Y; Kurokawa, K; Maeda, K; Miyata, T; van Ypersele de Strihou, C; Wada, Y; Yasuda, Y | 1 |
Horie, K; Kurokawa, K; Maeda, K; Miyata, T; Sobue, G; Takeda, A; Yasuda, T; Yasuda, Y | 1 |
Baynes, JW; Lyons, TJ; McCance, DR; Thorpe, SR; Wells-Knecht, MC | 1 |
Horie, K; Kurokawa, K; Maeda, K; Miyata, S; Miyata, T; Monnier, VM; Sakai, H; Sugiyama, S; van Ypersole de Strihou, C; Witztum, JL | 1 |
Buijs, MJ; Damen, JJ; Kleter, GA; Ten Cate, JM | 1 |
Doyu, M; Goto, Y; Horie, K; Inagaki, T; Maeda, K; Miyata, T; Sobue, G; Takeda, A; Wakai, M; Watanabe, M; Yasuda, T; Yasuda, Y | 1 |
Horiuchi, S; Kimura, T; Miyakawa, T; Miyata, T; Takamatsu, J | 1 |
Baynes, JW; Fu, MX; Kurokawa, K; Miyata, T; Thorpe, SR; van Ypersele de Strihou, C | 1 |
Hermon, M; Hoeger, H; Lubec, B; Lubec, G | 1 |
Aoyama, I; Hirasawa, Y; Miyazaki, S; Miyazaki, T; Morita, T; Niwa, T; Shimokata, K; Takayama, F; Tsukushi, S | 1 |
Kurokawa, K; Miyata, T; van Ypersele de Strihou, C | 1 |
Aotaki-Keen, A; Handa, JT; Hjelmeland, LM; Lutty, GA; Matsunaga, H; Miyata, T; te Koppele, JM; Verzijl, N | 1 |
Aoyama, I; Katsuzaki, T; Miyazaki, T; Niwa, T; Shimokata, K; Takayama, F; Tsukushi, S | 1 |
Daimon, M; Eguchi, H; Hirata, A; Igarashi, M; Kato, T; Manaka, H; Ohnuma, H; Ono, Y; Saito, T; Yamaguchi, H | 1 |
Aotaki-Keen, A; Farboud, B; Handa, JT; Hjelmeland, LM; Miyata, T | 1 |
Baynes, JW; Litchfield, JE; Thorpe, SR | 1 |
Hashimoto, A; Hyodo, T; Izumi, G; Kumano, K; Sakai, T; Shibata, K; Wang, H; Yokota, S | 1 |
Danielsson, R; Fogarty, JF; Frank, A; Monnier, VM; Sell, DR | 1 |
Araki, A; Deoreo, PB; Erhard, P; Glomb, MA; Kader-Attia, FA; Monnier, VM; Weiss, MF; Wu, YC | 1 |
Fujita, Y; Hirano, H; Horie, K; Izuhara, Y; Kurokawa, K; Miyata, T; Saito, A; Uchida, K; Ueda, Y; van Ypersele de Strihou, C | 1 |
Bank, RA; Bayliss, MT; Baynes, JW; Bijlsma, JW; DeGroot, J; Lafeber, FP; Oldehinkel, E; Tekoppele, JM; Thorpe, SR; Verzijl, N | 1 |
Asayama, K; Hirano, A; Horiuchi, S; Jono, T; Kato, S; Kobayashi, M; Miyata, S; Nagai, R; Sasaki, S; Shibata, N | 1 |
D'Agati, VD; Fu, C; Kislinger, T; Markowitz, GS; Pischetsrieder, M; Schmidt, AM; Stern, D; Taguchi, A; Tanji, N | 1 |
Asahi, K; Inagi, R; Izuhara, Y; Kurokawa, K; Miyata, T; Saito, A; Ueda, Y; VAN Ypersele DE Strihou, C | 1 |
Bank, RA; Baynes, JW; Bijlsma, JW; DeGroot, J; Lafeber, FP; Lyons, TJ; Shaw, JN; TeKoppele, JM; Thorpe, SR; Verzijl, N | 1 |
Ando, S; Horiuchi, S; Meng, J; Nagai, R; Sakata, N; Sasatomi, Y; Takebayashi, S; Uesugi, N | 1 |
Goto, C; Kasahara, Y; Koizumi, S; Miyata, T; Morimoto, K; Ohta, K; Seki, H; Shimizu, M; Toma, T; Yachie, A; Yang, Y; Yokoyama, H | 1 |
Hashiguchi, T; Iwamoto, H; Maruyama, I; Miura, M; Motomiya, Y; Okamura, H; Uchimura, T; Uji, Y | 1 |
Franke, S; John, U; Kauf, E; Misselwitz, J; Stein, G | 1 |
Horiuchi, S; Jono, T; Kimura, T; Kitamura, T; Miyazaki, K; Nagai, R; Takamatsu, J; Yuzuriha, T | 1 |
Busch, M; Franke, C; Franke, S; Müller, A; Niwa, T; Stein, G; Wendt, T | 1 |
Blum, M; Dawczynski, J; Franke, S; Kubetschka, U; Stein, F; Stein, G; Strobel, J | 1 |
Chibber, R; Ferro, A; Kohner, E; Ritter, J; Ruggerio, D; Ruggiero, D; Xu, B | 1 |
Franke, S; Hein, G; Lehmann, G; Stein, G; Wiegand, R | 1 |
Dawczynski, J; Franke, S; Niwa, T; Stahl, P; Stein, G; Strobel, J | 1 |
Culbertson, SM; Ingold, KU; Morrison, LD; Vassilenko, EI | 1 |
Braun, A; Busch, M; Fleck, C; Franke, S; Müller, A; Müller, UA; Schiel, R; Stein, G | 1 |
Hishida, A; Kato, A; Odamaki, M | 1 |
DeGroot, J; Hughes, TE; Kiers, GH; Quinn, D; TeKoppele, JM; Valencia, JV; Weldon, SC | 1 |
Chamson, lA; Frey, J; Granouillet, OR; Meli, M; Perier, C; Reynaud, E | 1 |
Chamson, A; Frey, J; Granouillet, R; Meli, M; Perier, C; Reynaud, E | 1 |
Aizawa, K; Hirano, K; Inakuma, T; Kiho, T; Usui, S | 1 |
Arima, Y; Hattori, Y; Miyachi, Y; Nishigori, C | 1 |
Chihara, J; Horiuchi, S; Moh, A; Nagai, R; Sakata, N; Takebayashi, S; Tateishi, K | 1 |
Carp, RI; Choi, EK; Choi, YG; Jeon, YC; Kascsak, RJ; Kim, JI; Kim, YS; Park, SJ; Rubenstein, R | 1 |
Appel, T; Franke, S; Kientsch-Engel, R; Müller, UA; Ross, IS; Schiel, R; Stein, G; Voigt, U | 1 |
Ahmed, N; Horiuchi, S; Jono, T; Lin, X; Nagai, R; Takeya, M; Thornalley, PJ | 1 |
Hirata, K; Kubo, K | 1 |
Fragedaki, E; Frischmann, M; Heidland, A; Klassen, A; Nebel, M; Niwa, T; Pischetsrieder, M; Schupp, N; Sebekova, K; Stopper, H; Vienken, J; Völkel, W | 1 |
Bassal, S; Cooper, ME; Deemer, ER; El-Osta, A; Forbes, JM; Jerums, G; Long, DM; Osicka, TM; Panagiotopoulos, S; Pete, J; Thallas-Bonke, V; Thomas, MC; Thorpe, SR | 1 |
Amano, S; Horiuchi, S; Kaji, Y; Koito, W; Okamoto, F; Oshika, T | 1 |
Boissonneault, GA; Bruckner, GG; Cervantes-Laurean, D; Halaweish, I; Jacobson, EL; Schramm, DD | 1 |
Anraku, M; Kitamura, K; Maruyama, T; Mera, K; Nakajou, K; Otagiri, M; Tomita, K | 1 |
Amano, S; Fukayama, M; Kaji, Y; Nagai, R; Oshika, T; Takazawa, Y | 1 |
Durante, A; Monacelli, F; Odetti, P; Poggi, A; Storace, D; Traverso, N; Viviani, GL | 1 |
Iwamoto, Y; Miura, J; Osawa, M; Uchigata, Y; Watanabe, T; Yamamoto, H; Yamamoto, Y; Yonekura, H | 1 |
Baynes, JW; den Hollander, NC; Graaff, R; Mulder, DJ; Smit, AJ; Smit, GP; Thorpe, SR | 1 |
Fujimoto, D; Iijima, K; Irie, S | 1 |
Fujiwara, Y; Ikeda, T; Iwao, Y; Mera, K; Motomura, K; Nagai, M; Nagai, R; Otagiri, M; Takeo, K; Tsurushima, K; Yoshitomi, M | 1 |
Niwa, T; Taki, K; Tsuruta, Y | 1 |
Busch, M; Franke, S; Rohde, RD; Stein, G; Wolf, G | 1 |
Lin, CC; Yin, MC | 1 |
Hartog, JW; Huisman, RM; Hummel, YM; Miyata, T; Schalkwijk, CG; Smit, AJ; Van Veldhuisen, DJ; Voors, AA | 1 |
Hartog, JW; Voors, AA; Willemsen, S | 1 |
Crabb, JW; Gu, J; Gu, X; Nagaraj, RH; Ni, J; Yuan, X; Yue, X | 1 |
Fujimoto, S; Miyazaki, A; Yoshikawa, T | 1 |
Fujiwara, Y; Ikeda, T; Kiyota, N; Motomura, K; Nagai, R; Nohara, T; Takeya, M; Tsurushima, K | 1 |
Choi, YG; Lim, S | 1 |
Horie, T; Kemi, M; Moriyama, T; Okumura, C; Yoshihara, K | 1 |
Galli, F; Libetta, C; Montaldi, M; Palazzetti, I; Pilolli, F; Piroddi, M; Quintaliani, G; Valentina, V | 1 |
Eguchi, N; Hirohama, J; Jinno, M; Miyazaki, A; Takeuchi, M; Teruya, K; Watanabe, A | 1 |
Izumi, M; Maruyama, T; Mera, K; Nagai, R; Otagiri, M; Takeo, K | 1 |
Aiello, LP; Asztalos, BF; Cavallerano, JD; Doria, A; Keenan, HA; King, GL; Monnier, VM; Schaefer, EJ; Sell, DR; Strauch, CM; Sun, JK | 1 |
Beisswenger, PJ; Corstjens, H; Howell, S; Mackenzie, T; Matsui, MS; Muizzuddin, N | 1 |
Dvorakova, E; Holada, K; Janouskova, O; Panigaj, M; Prouza, M | 1 |
Akizawa, T; Aoshima, Y; Hirai, Y; Honda, H; Hosaka, N; Michihata, T | 1 |
Begall, S; Dammann, P; Monnier, VM; Sell, DR; Strauch, C | 1 |
Hartog, JW; Hillege, HL; Jaarsma, T; Roze, JF; Schalkwijk, C; van der Horst, IC; van der Meer, P; van Veldhuisen, DJ; Voors, AA; Willemsen, S | 1 |
Abetew, D; Christianson, C; Enquobahrie, DA; Hevner, K; Qiu, CF; Sheaff, C; Williams, MA; Zimmer, J | 1 |
Bidasee, KR; Kutty, S; Moore, CJ; Nagai, R; Shao, CH; Singh, J | 1 |
Heilmann, M; Ilchmann, A; Toda, M; Vieths, S | 1 |
Borghi, R; Monacelli, F; Odetti, P; Pacini, D; Serrati, C; Traverso, N | 1 |
Engelen, L; Franssen, FM; Gopal, P; Reynaert, NL; Rutten, EP; Schalkwijk, CG; Scheijen, JL; Wouters, EF | 1 |
Dekker, JM; Engelen, L; Ferreira, I; Hanssen, NM; Huijberts, MS; Nijpels, G; Schalkwijk, CG; Scheijen, JL; Stehouwer, CD; van der Kallen, CJ; van Greevenbroek, MM | 1 |
Colhoun, HM; Schalkwijk, CG; Scheijen, JL; Schram, MT; Stehouwer, CD; van Eupen, MG | 1 |
Barzilay, JI; Fonseca, V; Goldfine, AB; Jablonski, KA; Monnier, VM; Shoelson, SE; Strauch, C | 1 |
Addad, F; Dandana, A; Gillery, P; Hammami, M; Jaisson, S; Kerkeni, M; Weiss, IS | 1 |
Ahmad, S; Ashraf, JM; Choi, I; Jan, AT; Khan, RH; Lee, EJ; Rabbani, G | 1 |
Atabak, S; Hedayati, M; Imani, H; Najafi, I; Rahmani, L; Tabibi, H | 1 |
Jing, Z; Kuang, L; Liu, N; Yang, J | 1 |
Ho, JJ; Hsu, CC; Hsu, JY; Yang, HT; Yin, MC | 1 |
Fujiwara, Y; Ikeda, T; Miyashita, H; Nagai, R; Nakashima, K; Yoshimitsu, H | 1 |
He, J; Jing, Z; Kuang, L; Liu, N; Sun, Z; Wang, Y; Yang, J | 1 |
Hirata, T; Ikeda, T; Kanagawa, A; Moroishi, N; Nagai, M; Nagai, R; Nakajima, A; Ohno, R; Shirakawa, J; Sugawa, H | 1 |
Brunner-La Rocca, HP; Dekker, JM; Henry, RM; Linssen, PB; Nijpels, G; Schalkwijk, CG; Stehouwer, CD | 1 |
Andican, A; Andican, G; Burcak, G; Kurt, A; Siva, ZO | 1 |
Hsia, TC; Mong, MC; Yin, MC | 1 |
Annaka, H; Homma, S; Nomi, Y; Ohkura, T; Otsuka, Y; Sato, S; Suzuki, E; Ueta, E; Yamamoto, K | 1 |
Berriche, O; Bouzidi, H; Haddad, M; Hammami, M; Kerkeni, M; Knani, I | 1 |
Ahmad, S; Alatar, AA; Faisal, M | 1 |
Bergaoui, N; Bouzidi, H; Hammami, M; Kerkeni, M; Knani, I; Zrour, S | 1 |
Cocuzzi, E; Flückiger, R; Kern, TS; Medof, ME; Nagaraj, RH; Shoham, M | 1 |
Alizadeh, M; Kheirouri, S | 1 |
Cleland, TP; Sroga, GE; Thomas, CJ; Vashishth, D | 1 |
Abruzzo, PM; Anwar, A; Bolotta, A; Ghezzo, A; Marini, M; Pasha, S; Posar, A; Rabbani, N; Rajpoot, K; Thornalley, PJ; Visconti, P | 1 |
Bergero, D; Borghi, R; Bovero, A; Bruni, N; Monacelli, F; Nery, J; Odetti, P; Prola, L; Schiavone, A; Traverso, N; Valle, E; Vergnano, D | 1 |
Barbé, F; Benabdelhak, I; Bermúdez-López, M; Betriu, À; Colàs-Campàs, L; Farràs, C; Fernández, E; Hernández, C; Hernández, M; Jové, M; Kerkeni, M; Lecube, A; Manuel Valdivielso, J; Martínez-Alonso, M; Miquel, E; Ortega, M; Pamplona, R; Polanco, D; Portero-Otin, M; Purroy, F; Rius, F; Sánchez, E; Sánchez-de-la-Torre, M; Simó, R; Suárez, G; Torres, G; Yeramian, A | 1 |
Alizadeh, M; Asghari Jafarabadi, M; Foroumandi, E; Kheirouri, S | 1 |
Cai, W; Del Castillo, MD; Fernandez-Gomez, B; Martinez-Saez, N; Uribarri, J | 1 |
Liu, YT; Mong, MC; Pai, PY; Wang, ZH; Yang, YC; Yin, MC | 1 |
Fülöp, T; Haddad, M; Landri, S; Lepage, A; Perrotte, M; Ramassamy, C | 1 |
Ahmad, S; Alatar, AA; Faisal, M; Rehman, S | 1 |
Fujiwara, Y; Hattori, S; Ichikawa, H; Iijima, K; Kinoshita, S; Mera, K; Nagai, M; Nagai, R; Shimasaki, S; Shirakawa, JI; Taga, Y | 1 |
Alizadeh, M; Foroumandi, E; Kheirouri, S | 1 |
Bast, A; Opperhuizen, A; van der Lugt, T; van Leeuwen, S; Venema, K; Vrolijk, MF | 1 |
Miyazaki, A; Nakamura, Y; Nakano, M; Saito, M; Shiraki, M; Suzuki, T; Takahashi, J | 1 |
Blachut, D; Damasiewicz-Bodzek, A; Nowak, A; Nowalany-Kozielska, E; Przywara-Chowaniec, B; Tyrpień-Golder, K | 1 |
5 review(s) available for arginine and n(6)-carboxymethyllysine
Article | Year |
---|---|
Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes.
Topics: Aging; Animals; Arginine; Collagen; Cross-Linking Reagents; Diabetes Complications; Diabetes Mellitus; Elastin; Glycation End Products, Advanced; Glycosylation; Humans; Imidazoles; Lysine; Maillard Reaction; Malondialdehyde; Norleucine; Pyrroles | 1996 |
New biomarkers of Maillard reaction damage to proteins.
Topics: Aging; Arginine; Biomarkers; Diabetes Complications; Diabetes Mellitus; Glycation End Products, Advanced; Glycosylation; Humans; Lysine; Maillard Reaction; Molecular Structure; Norleucine; Oxidation-Reduction; Proteins; Pyrroles | 1996 |
Carbonyl stress and long-term uremic complications.
Topics: Arginine; Glycation End Products, Advanced; Humans; Lysine; Oxidative Stress; Uremia | 1998 |
The Maillard reaction and food allergies: is there a link?
Topics: Arginine; Dendritic Cells; Food Hypersensitivity; Glycation End Products, Advanced; Humans; Immunoglobulin E; Lysine; Maillard Reaction; Norleucine; Pyrroles; Receptors, Scavenger; T-Lymphocytes | 2014 |
Curcumin against advanced glycation end products (AGEs) and AGEs-induced detrimental agents.
Topics: Animals; Antioxidants; Apoptosis; Arginine; Cell Death; Cell Proliferation; Curcumin; Databases, Factual; DNA Damage; Glycation End Products, Advanced; Humans; Lysine; NF-kappa B; Oxidative Stress; Pyruvaldehyde; Receptor for Advanced Glycation End Products | 2019 |
7 trial(s) available for arginine and n(6)-carboxymethyllysine
Article | Year |
---|---|
Improvement of the quality of diabetes control and decrease in the concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus: results from a 10 year-prospective, population-based survey on the quality of diabetes
Topics: Adolescent; Adult; Arginine; Creatinine; Diabetes Complications; Diabetes Mellitus; Female; Germany; Glycation End Products, Advanced; Health Surveys; Humans; Insulin; Longitudinal Studies; Lysine; Male; Middle Aged; Prospective Studies; Time Factors | 2004 |
Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis.
Topics: Adult; Aged; Arginine; C-Reactive Protein; Cross-Sectional Studies; DNA Damage; Female; Glycation End Products, Advanced; Humans; Imidazoles; Interleukin-6; Kidney Failure, Chronic; Lysine; Male; Micronucleus Tests; Middle Aged; Reference Values; Renal Dialysis | 2005 |
Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Arginine; Biphenyl Compounds; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Hypertension; Irbesartan; Linear Models; Lysine; Male; Middle Aged; Statistics, Nonparametric; Tetrazoles | 2008 |
Decrease in serum levels of advanced glycation end-products by short-term lifestyle modification in non-diabetic middle-aged females.
Topics: Adiposity; Adult; Aged; Arginine; Body Weight; Case-Control Studies; Diabetes Mellitus; Exercise; Female; Glycation End Products, Advanced; Humans; Life Style; Lysine; Middle Aged; Regression Analysis; Time Factors; Walking | 2009 |
Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; Female; Glycation End Products, Advanced; Humans; Hypertension, Renal; Imidazoles; Inflammation; Kidney Failure, Chronic; Lysine; Male; Olmesartan Medoxomil; Oxidative Stress; Pilot Projects; Prospective Studies; Renal Dialysis; Telmisartan; Tetrazoles; Treatment Outcome | 2012 |
The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes.
Topics: Adiponectin; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Pyruvaldehyde; Salicylates | 2014 |
Effects of ginger on serum glucose, advanced glycation end products, and inflammation in peritoneal dialysis patients.
Topics: Adult; Aged; Arginine; Blood Glucose; C-Reactive Protein; Dietary Supplements; Double-Blind Method; E-Selectin; Female; Glycation End Products, Advanced; Humans; Inflammation; Intercellular Adhesion Molecule-1; Kidney Failure, Chronic; Lysine; Male; Malondialdehyde; Middle Aged; Peritoneal Dialysis; Treatment Outcome; Vascular Cell Adhesion Molecule-1; Zingiber officinale | 2015 |
118 other study(ies) available for arginine and n(6)-carboxymethyllysine
Article | Year |
---|---|
L-arginine reduces glomerular basement membrane collagen N epsilon-carboxymethyllysine in the diabetic db/db mouse.
Topics: Administration, Oral; Animals; Arginine; Basement Membrane; Collagen; Diabetes Mellitus, Experimental; Glycosylation; Kidney Glomerulus; Lysine; Mice; Mice, Mutant Strains | 1992 |
Identification of the carboxymethyllysine residue in the advanced stage of glycated human serum albumin.
Topics: Arginine; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Lysine; Magnetic Resonance Spectroscopy; Oxidation-Reduction; Serum Albumin; Tyrosine | 1992 |
Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus.
Topics: Arginine; Blood Glucose; Collagen; Diabetes Mellitus, Type 1; Humans; Hyperglycemia; Lysine; Maillard Reaction; Skin | 1991 |
Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts.
Topics: Aged; Arginine; Cataract; Cataract Extraction; Crystallins; Diabetic Retinopathy; Female; Glycosylation; Humans; Lysine; Male | 1991 |
Pathways of formation of glycoxidation products during glycation of collagen.
Topics: Animals; Arginine; Carbon Isotopes; Collagen; Glucose; Glycosylation; Lysine; Oxidation-Reduction; Phosphates; Rats | 1995 |
Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen.
Topics: Aging; Animals; Arginine; Blood Proteins; Chromatography, High Pressure Liquid; Collagen; Energy Intake; Female; Food Deprivation; Glycation End Products, Advanced; Lysine; Oxidation-Reduction; Rats; Rats, Inbred BN; Skin | 1995 |
L-arginine reduces heart collagen accumulation in the diabetic db/db mouse.
Topics: Animals; Arginine; Collagen; Diabetes Mellitus; Hydroxyproline; Isomerism; Lysine; Mice; Mice, Mutant Strains; Myocardium; Tyrosine | 1994 |
L-arginine reduces kidney collagen accumulation and N-epsilon-(carboxymethyl)lysine in the aging NMRI-mouse.
Topics: Aging; Animals; Arginine; Basement Membrane; Collagen; Electrophoresis, Polyacrylamide Gel; Female; Glycosylation; Hydroxyproline; Kidney; Kidney Glomerulus; Lysine; Mice | 1994 |
Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction.
Topics: Animals; Antioxidants; Arginine; Chelating Agents; Chromatography, High Pressure Liquid; Collagen; Cross-Linking Reagents; Electrophoresis, Polyacrylamide Gel; Female; Glucose; Glycosylation; Kinetics; Lysine; Maillard Reaction; Oxidation-Reduction; Pentetic Acid; Rats; Rats, Sprague-Dawley; Spectrometry, Fluorescence; Tendons | 1994 |
Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Collagen; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Maillard Reaction; Male; Microcirculation; Middle Aged; Skin | 1993 |
Identification of advanced glycation end products of the Maillard reaction in Pick's disease.
Topics: Aged; Arginine; Brain; Dementia; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lysine; Maillard Reaction | 1996 |
Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
Topics: Amino Acid Sequence; Amyloid; Arginine; Ascorbic Acid; beta 2-Microglobulin; Glycation End Products, Advanced; Humans; Immunohistochemistry; In Vitro Techniques; Kidney Failure, Chronic; Lysine; Molecular Structure; Oxidative Stress; Renal Dialysis; Spectrometry, Fluorescence; Spectrometry, Mass, Fast Atom Bombardment; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Uremia | 1997 |
Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons.
Topics: Adolescent; Aged; Aging; Alzheimer Disease; Arginine; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lipofuscin; Lysine; Nerve Degeneration; Nerve Tissue Proteins; Neurons | 1997 |
Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against a generalized increase in oxidative stress in diabetes.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Arginine; Child; Child, Preschool; Collagen; Diabetes Mellitus; Glucose; Humans; Infant; Infant, Newborn; Lysine; Methionine; Middle Aged; Oxidative Stress; Skin; Time Factors; Tyrosine | 1997 |
Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
Topics: Adolescent; Adult; Aged; Animals; Antibodies; Arginine; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Immunoenzyme Techniques; Kidney Glomerulus; Lipid Peroxidation; Lysine; Male; Malondialdehyde; Mice; Middle Aged; Nephrotic Syndrome; Norleucine; Pyrroles; Rabbits | 1997 |
Modification of amino acid residues in carious dentin matrix.
Topics: Amino Acids; Arginine; Chromatography, High Pressure Liquid; Collagen; Cross-Linking Reagents; Dental Caries; Dentin; Extracellular Matrix Proteins; Glycation End Products, Advanced; Glycosylation; Humans; Hydrolysis; Hydroxyproline; Lysine; Maillard Reaction; Ninhydrin; Protein Processing, Post-Translational; Spectrometry, Fluorescence | 1998 |
Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease brain.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arginine; Astrocytes; Cytoplasmic Granules; Extracellular Space; Glycoconjugates; Hippocampus; Humans; Lysine; Microglia; Staining and Labeling | 1998 |
Localization of identified advanced glycation end-product structures, N epsilon(carboxymethyl)lysine and pentosidine, in age-related inclusions in human brains.
Topics: Aged; Aged, 80 and over; Aging; Arginine; Brain; Entorhinal Cortex; Glycation End Products, Advanced; Hippocampus; Humans; Immunoenzyme Techniques; Inclusion Bodies; Lipofuscin; Lysine; Maillard Reaction; Middle Aged; Ubiquitins | 1998 |
Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?
Topics: Adult; Aged; Arginine; Carbohydrates; Case-Control Studies; Glycation End Products, Advanced; Humans; Lipid Peroxidation; Lipids; Lysine; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Uremia | 1998 |
Aromatic hydroxylation in animal models of diabetes mellitus.
Topics: Animals; Arginine; Blood Glucose; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Fructosamine; Hydroxylation; Kidney; Lysine; Malondialdehyde; Mice; Rats; Rats, Inbred BB; Rats, Sprague-Dawley; Streptozocin; Tyrosine | 1998 |
Immunohistochemical detection of imidazolone and N(epsilon)-(carboxymethyl)lysine in aortas of hemodialysis patients.
Topics: Aged; Aorta; Arginine; Arteriosclerosis; Deoxyglucose; Female; Glyoxal; Humans; Imidazoles; Immunohistochemistry; Lysine; Male; Middle Aged; Pyruvaldehyde; Renal Dialysis; Uremia | 1998 |
Increase in the advanced glycation end product pentosidine in Bruch's membrane with age.
Topics: Adult; Aged; Aged, 80 and over; Aging; Arginine; Bruch Membrane; Choroid; Chromatography, High Pressure Liquid; Diabetic Retinopathy; Glycation End Products, Advanced; Humans; Immunoenzyme Techniques; Infant; Lysine; Middle Aged; Pigment Epithelium of Eye; Retinal Drusen | 1999 |
Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway.
Topics: Adult; Aged; Aldehyde Reductase; Arginine; Creatinine; Deoxyglucose; Diabetic Nephropathies; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Female; Glycation End Products, Advanced; Hemoglobins; Humans; Imidazoles; In Vitro Techniques; Lysine; Male; Middle Aged; Polymers; Renal Dialysis; Sorbitol; Uremia | 1999 |
Increased serum levels of pentosidine, but not carboxymethyl lysine, in type 2 diabetes without obvious diabetic nephropathy.
Topics: Albuminuria; Arginine; Biomarkers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Middle Aged; Reference Values | 1999 |
Development of a polyclonal antibody with broad epitope specificity for advanced glycation endproducts and localization of these epitopes in Bruch's membrane of the aging eye.
Topics: Acetaldehyde; Adult; Aged; Aged, 80 and over; Aging; Animals; Antibodies; Antibody Specificity; Arginine; Bruch Membrane; Cattle; Choroid Plexus; Extracellular Matrix Proteins; Glycation End Products, Advanced; Humans; Immunohistochemistry; Infant; Lysine; Middle Aged | 1999 |
Oxygen is not required for the browning and crosslinking of protein by pentoses: relevance to Maillard reactions in vivo.
Topics: Aging; Animals; Antioxidants; Arabinose; Arginine; Cattle; Cross-Linking Reagents; Diabetes Mellitus; Fluorescence; Glucose; In Vitro Techniques; Lysine; Maillard Reaction; Oxidation-Reduction; Oxygen; Pentoses; Proteins; Ribonucleases | 1999 |
In vitro and in vivo generation and kinetics of glycosylation products in peritoneal dialysis effluents.
Topics: Adult; Arginine; Dialysis Solutions; Glycation End Products, Advanced; Humans; In Vitro Techniques; Lysine; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum | 1998 |
A syndrome of molybdenosis, copper deficiency, and type 2 diabetes in the moose population of south-west Sweden.
Topics: Animals; Arginine; Case-Control Studies; Copper; Deer; Deficiency Diseases; Diabetes Mellitus, Type 2; Glycation End Products, Advanced; Kidney; Liver; Lysine; Molybdenum; Sweden | 2000 |
Mechanisms for the formation of glycoxidation products in end-stage renal disease.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Enzyme Inhibitors; Female; Glucose; Glycation End Products, Advanced; Guanidines; Humans; Kidney Failure, Chronic; Lysine; Maillard Reaction; Male; Middle Aged; Oxidation-Reduction; Peritoneal Dialysis; Renal Dialysis | 2000 |
Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
Topics: Adult; Aged; Aldehydes; Arginine; Ascitic Fluid; Dialysis Solutions; Filtration; Glucose; Glycation End Products, Advanced; Hot Temperature; Humans; Kidney Failure, Chronic; Lipid Peroxidation; Lysine; Middle Aged; Peritoneal Dialysis; Peritoneum; Sterilization; Uremia | 2000 |
Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Arginine; Cartilage, Articular; Child; Child, Preschool; Collagen; Collagenases; Cross-Linking Reagents; Female; Femur; Glycation End Products, Advanced; Humans; Lysine; Maillard Reaction; Male; Middle Aged; Skin; Spectrometry, Fluorescence | 2000 |
Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acrolein; Adult; Aged; Aldehydes; Amyotrophic Lateral Sclerosis; Arginine; Deoxyguanosine; Glycosylation; Humans; Imidazoles; Lipid Peroxidation; Lysine; Male; Middle Aged; Motor Neurons; Oxidative Stress; Spinal Cord; Superoxide Dismutase | 2000 |
Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
Topics: Adult; Antibodies; Arginine; Diabetic Nephropathies; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; Kidney Diseases; Lysine; Male; Middle Aged; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reference Values; RNA, Messenger | 2000 |
Mechanism of the inhibitory effect of OPB-9195 [(+/-)-2-isopropylidenehydrazono-4-oxo-thiazolidin-5-yla cetanilide] on advanced glycation end product and advanced lipoxidation end product formation.
Topics: Aldehydes; Arachidonic Acid; Arginine; Deoxyglucose; Dialysis Solutions; Glycation End Products, Advanced; Glyoxal; Guanidines; Lipid Metabolism; Lysine; Malondialdehyde; Oxidation-Reduction; Peritoneal Dialysis; Prodrugs; Pyruvaldehyde; Thiadiazoles; Thiazolidines | 2000 |
Effect of collagen turnover on the accumulation of advanced glycation end products.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Arginine; Aspartic Acid; Cartilage, Articular; Child; Child, Preschool; Chondrocytes; Collagen; Glycation End Products, Advanced; Humans; Kinetics; Lysine; Middle Aged; Skin | 2000 |
Possible involvement of altered RGD sequence in reduced adhesive and spreading activities of advanced glycation end product-modified fibronectin to vascular smooth muscle cells.
Topics: Amino Acids; Animals; Arginine; Cell Adhesion; Cells, Cultured; Collagen; Electrophoresis, Polyacrylamide Gel; Fibronectins; Glycation End Products, Advanced; Glycosylation; Humans; Immunochemistry; Lysine; Muscle, Smooth, Vascular; Oligopeptides; Sodium Dodecyl Sulfate; Swine | 2000 |
Cytoprotective role of heme oxygenase (HO)-1 in human kidney with various renal diseases.
Topics: Adolescent; Aged; Arginine; Child; Cytoprotection; Hematuria; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Immunohistochemistry; Kidney; Kidney Diseases; Lysine; Membrane Proteins; Proteinuria | 2001 |
Marked increases in macrophage colony-stimulating factor and interleukin-18 in maintenance hemodialysis patients: comparative study of advanced glycation end products, carboxymethyllysine and pentosidine.
Topics: Adult; Aged; Arginine; Cytokines; Female; Glycation End Products, Advanced; Hemoglobins; Humans; Interleukin-18; Lysine; Macrophage Colony-Stimulating Factor; Male; Middle Aged; Regression Analysis; Renal Dialysis | 2002 |
Advanced glycation end products in children with chronic renal failure and type 1 diabetes.
Topics: Adolescent; Arginine; Child; Child, Preschool; Creatinine; Diabetes Mellitus, Type 1; Female; Glycation End Products, Advanced; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lysine; Male; Reference Values | 2002 |
Accumulation of imidazolone, pentosidine and N(epsilon)-(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain.
Topics: Adult; Aged; Aged, 80 and over; Aging; Arginine; Female; Glycation End Products, Advanced; Humans; Imidazoles; Immunohistochemistry; Lysine; Male; Middle Aged; Pyramidal Cells | 2002 |
Are advanced glycation end products cardiovascular risk factors in patients with CRF?
Topics: Adult; Aged; Aged, 80 and over; Arginine; Cardiovascular Diseases; Diabetes Mellitus; Female; Glycation End Products, Advanced; Humans; Hypertrophy, Left Ventricular; Imidazoles; Kidney Failure, Chronic; Kidney Transplantation; Lysine; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Risk Factors | 2003 |
Advanced glycation end-products in anterior chamber aqueous of cataractous patients.
Topics: Aged; Albumins; Aqueous Humor; Arginine; Blotting, Western; Cataract; Chromatography, High Pressure Liquid; Electrophoresis, Polyacrylamide Gel; Female; Glycation End Products, Advanced; Humans; Imidazoles; Lysine; Male; Middle Aged; Protein Binding | 2003 |
Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products.
Topics: Animals; Antibodies; Aorta; Arginine; Blood Pressure; Cells, Cultured; Citrulline; Diabetes Mellitus; Endothelium, Vascular; Enzyme Inhibitors; Female; Femoral Artery; Glycation End Products, Advanced; Humans; In Vitro Techniques; Lysine; Male; Models, Biological; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rabbits; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Vasodilation | 2003 |
Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis.
Topics: Adult; Aged; Analysis of Variance; Arginine; Bone Resorption; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Osteoporosis | 2003 |
Increased levels of advanced glycation end products in human cataractous lenses.
Topics: Aged; Antibodies, Monoclonal; Arginine; Cataract; Diabetes Mellitus; Glycation End Products, Advanced; Humans; Imidazoles; Immunoenzyme Techniques; Lens, Crystalline; Lysine; Middle Aged; Oxidation-Reduction | 2003 |
Paradoxical impact of antioxidants on post-Amadori glycoxidation: Counterintuitive increase in the yields of pentosidine and Nepsilon-carboxymethyllysine using a novel multifunctional pyridoxamine derivative.
Topics: Antioxidants; Arginine; Biochemistry; Chromatography, High Pressure Liquid; Cross-Linking Reagents; Dose-Response Relationship, Drug; Gas Chromatography-Mass Spectrometry; Glucose; Glycation End Products, Advanced; Ions; Lysine; Models, Chemical; Pyridoxamine; Ribose; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors | 2003 |
Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycation End Products, Advanced; Homocysteine; Humans; Kidney Transplantation; Lysine; Middle Aged; Renal Dialysis; Renal Insufficiency; Risk Factors; Smoking | 2003 |
Association between blood indoxyl sulfate and carbonyl stress marker in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Arginine; Biomarkers; Blood Proteins; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Female; Homocysteine; Humans; Indican; Lysine; Male; Middle Aged; Regression Analysis; Renal Dialysis; Time Factors | 2003 |
Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
Topics: Acetaldehyde; Amines; Arginine; Diabetes Mellitus; Fructose; Glucose; Glycation End Products, Advanced; Glyoxylates; Humans; Ligands; Lysine; Membrane Proteins; Molecular Weight; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Recombinant Proteins; Regression Analysis; Ribose; Serum Albumin, Bovine; Spectrometry, Fluorescence | 2004 |
Changes in glycation of fibrous type I collagen during long-term in vitro incubation with glucose.
Topics: Animals; Arginine; Cattle; Chromatography, High Pressure Liquid; Collagen Type I; Fructosamine; Glucose; Glycosylation; Lysine; Solubility; Time Factors | 2003 |
In vitro glycoxidation of insoluble fibrous type I collagen: solubilization and advanced glycation end products.
Topics: Amidines; Animals; Arginine; Cattle; Collagen Type I; Glycation End Products, Advanced; Glycosylation; Lysine; Solubility | 2003 |
Tomato paste fraction inhibiting the formation of advanced glycation end-products.
Topics: Arginine; Blotting, Western; Chemical Fractionation; Enzyme-Linked Immunosorbent Assay; Food; Glucose; Glycation End Products, Advanced; Lysine; Molecular Weight; Nitroblue Tetrazolium; Norleucine; Oxidation-Reduction; Pyrroles; Rutin; Serum Albumin, Bovine; Solanum lycopersicum; Spectrometry, Fluorescence | 2004 |
Photoaging and oxidative stress.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Arginine; Cells, Cultured; Deoxyguanosine; Fibroblasts; Humans; Lysine; Mice; Mice, Hairless; Oxidative Stress; Skin; Skin Aging; Tyrosine; Ultraviolet Rays | 2003 |
Increased production of urea hydrogen peroxide from Maillard reaction and a UHP-Fenton pathway related to glycoxidation damage in chronic renal failure.
Topics: Arginine; Female; Glycosides; Humans; Hydrogen Peroxide; Kidney; Kidney Failure, Chronic; Lysine; Maillard Reaction; Male; Middle Aged; Myocardium; Urea | 2004 |
Nonenzymatic glycation at the N terminus of pathogenic prion protein in transmissible spongiform encephalopathies.
Topics: Animals; Arginine; Astrocytes; Binding, Competitive; Blotting, Western; Brain; Cricetinae; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Glycosylation; Humans; Immunohistochemistry; Kinetics; Lysine; Mice; Mice, Inbred C57BL; Models, Biological; Oxygen; Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase; Peptides; Precipitin Tests; Prion Diseases; Prions; Protein Isoforms; Protein Processing, Post-Translational; Protein Structure, Tertiary; PrPSc Proteins | 2004 |
Nepsilon-(Carboxymethyl)lysine and 3-DG-imidazolone are major AGE structures in protein modification by 3-deoxyglucosone.
Topics: Adult; Aged; Antibodies, Monoclonal; Aorta; Arginine; Arteriosclerosis; Binding, Competitive; Chromatography; Chromatography, High Pressure Liquid; Cytoplasm; Deoxyglucose; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Foam Cells; Glycation End Products, Advanced; Humans; Imidazoles; Immunochemistry; Immunohistochemistry; Lysine; Male; Middle Aged; Models, Biological; Models, Chemical; Norleucine; Pyrroles; Temperature; Time Factors | 2004 |
Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
Topics: Arginine; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged | 2004 |
Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.
Topics: Alternative Splicing; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arginine; Blotting, Western; Cattle; Cells, Cultured; Collagen; Diabetic Nephropathies; DNA Primers; Endothelium, Vascular; Glycation End Products, Advanced; Humans; Immunohistochemistry; Immunoprecipitation; Kidney Cortex; Lysine; Male; Microscopy, Fluorescence; Molecular Weight; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; Skin; Time Factors; Up-Regulation | 2005 |
Immunohistochemical localization of advanced glycation end products in pinguecula.
Topics: Adult; Aged; Aging; Antibodies, Monoclonal; Arginine; Conjunctival Diseases; Female; Glycation End Products, Advanced; Humans; Imidazoles; Immunoenzyme Techniques; Lysine; Male; Middle Aged; Norleucine; Pyrroles | 2006 |
Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites.
Topics: Arginine; Chromatography, High Pressure Liquid; Collagen; Collagen Type I; Fluorescence; Glucose; Glycation End Products, Advanced; Lysine; Oxidation-Reduction; Rutin | 2006 |
Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Blood Proteins; Case-Control Studies; Diabetes Mellitus; Female; Glycation End Products, Advanced; Humans; Imidazoles; Kidney Failure, Chronic; Lysine; Male; Middle Aged; Neutrophils; Norleucine; Oxidative Stress; Protein Carbonylation; Pyrroles; Renal Dialysis; Respiratory Burst; Serum Albumin | 2005 |
Advanced glycation end product deposits in climatic droplet keratopathy.
Topics: Antibodies, Monoclonal; Arginine; Cornea; Corneal Diseases; Cross-Linking Reagents; Female; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lysine; Male; Middle Aged; Pyrroles | 2007 |
Effects of valsartan therapy on protein glycoxidation.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Arginine; Dinoprost; Female; Glycation End Products, Advanced; Glycosylation; Humans; Hypertension; Lysine; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Proteins; Tetrazoles; Valine; Valsartan | 2006 |
Endogenous secretory receptor for advanced glycation endproducts levels are correlated with serum pentosidine and CML in patients with type 1 diabetes.
Topics: Adolescent; Adult; Arginine; Diabetes Mellitus, Type 1; Female; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Regression Analysis | 2007 |
Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia.
Topics: Adolescent; Adult; Arginine; Atherosclerosis; Carotid Arteries; Collagen; Female; Glycation End Products, Advanced; Glycogen Storage Disease Type I; Humans; Lysine; Male; Oxidative Stress; Risk; Skin; Tunica Intima; Tunica Media | 2007 |
Amount of N(omega)-(Carboxymethyl)arginine generated in collagen and bovine serum albumin during glycation reactions is significantly different.
Topics: Animals; Arginine; Cattle; Collagen Type I; Glucose; Glycation End Products, Advanced; Lysine; Ribose; Serum Albumin, Bovine | 2007 |
Usefulness of antibodies for evaluating the biological significance of AGEs.
Topics: Aldehydes; Antibodies; Arginine; Glycation End Products, Advanced; Lysine | 2008 |
Cardiac troponin T and advanced glycation end-products in hemodialysis patients.
Topics: Adolescent; Adult; Arginine; Calcium; Child; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Humans; Infant; Lysine; Male; Renal Dialysis; Troponin T | 2008 |
Antiglycative and anti-VEGF effects of s-ethyl cysteine and s-propyl cysteine in kidney of diabetic mice.
Topics: Albuminuria; Animals; Arginine; Blood Glucose; Creatinine; Cysteine; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Kidney; Lysine; Male; Mice; Mice, Inbred BALB C; Organ Size; Vascular Endothelial Growth Factor A | 2008 |
Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients.
Topics: Age Factors; Arginine; Cardiac Volume; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Echocardiography; Echocardiography, Doppler; Echocardiography, Doppler, Color; Female; Fluorescence; Glycation End Products, Advanced; Heart Failure, Diastolic; Humans; Lysine; Male; Middle Aged; Myocardial Contraction; Renal Dialysis; Risk Factors; Sex Factors; Skin; Stroke Volume; Tandem Mass Spectrometry; Ventricular Dysfunction; Ventricular Function; Ventricular Pressure | 2008 |
Letter by Hartog et al. regarding article, "Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines".
Topics: Animals; Arginine; Collagen; Cross-Linking Reagents; Dogs; Glycation End Products, Advanced; Hypertension; Lysine; Muscle, Smooth, Vascular; Thiazoles | 2009 |
Plasma protein pentosidine and carboxymethyllysine, biomarkers for age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Arginine; Autoantibodies; Biomarkers; Blood Proteins; Case-Control Studies; Chromatography, Liquid; Female; Fluorometry; Humans; Logistic Models; Lysine; Macular Degeneration; Male; Mass Spectrometry; Middle Aged; Pyrroles | 2009 |
Astragalosides isolated from the root of astragalus radix inhibit the formation of advanced glycation end products.
Topics: Arginine; Astragalus Plant; Diabetes Complications; Glycation End Products, Advanced; Lysine; Plant Extracts; Plant Roots; Saponins; Triterpenes | 2009 |
Characterization of anti-advanced glycation end product antibodies to nonenzymatically lysine-derived and arginine-derived glycated products.
Topics: Animals; Antibodies; Arginine; Cattle; Cross Reactions; Glycation End Products, Advanced; Lysine; Rabbits; Serum Albumin, Bovine | 2009 |
Involvement of advanced glycation end-products, pentosidine and N(epsilon)-(carboxymethyl)lysine, in doxorubicin-induced cardiomyopathy in rats.
Topics: Animals; Antineoplastic Agents; Arginine; Blood Glucose; Cardiomyopathies; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Glycation End Products, Advanced; Immunohistochemistry; Lysine; Male; Rats | 2010 |
Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; C-Reactive Protein; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Diet; Energy Intake; Female; Glycation End Products, Advanced; Humans; Inflammation; Interleukin-6; Kidney Failure, Chronic; Lysine; Male; Malnutrition; Middle Aged; Nutrition Assessment; Pilot Projects; Regression Analysis; Renal Dialysis; Risk Factors | 2011 |
Advanced glycation end-products accumulation compromises embryonic development and achievement of pregnancy by assisted reproductive technology.
Topics: Aging; Arginine; Embryo Implantation; Embryonic Development; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Follicular Fluid; Glycation End Products, Advanced; Humans; Infertility; Lysine; Ovulation Induction; Pregnancy; Pregnancy Rate; Reproductive Techniques, Assisted; Retrospective Studies | 2011 |
An autoantibody against N(ε)-(carboxyethyl)lysine (CEL): possible involvement in the removal of CEL-modified proteins by macrophages.
Topics: Animals; Arginine; Autoantibodies; Glycation End Products, Advanced; Humans; Lysine; Macrophages, Peritoneal; Mice; Rabbits; Serum Albumin | 2011 |
Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.
Topics: Aged; Arginine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Middle Aged | 2011 |
Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes.
Topics: Adult; Arginine; Collagen; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Methionine; Middle Aged; Oxidative Stress; Skin; Skin Aging; Spectrometry, Fluorescence | 2012 |
Development of monoclonal antibodies specific for glycated prion protein.
Topics: Animals; Antibodies, Monoclonal; Arginine; Brain; Glycosylation; Humans; Hybridomas; Lysine; Mice; Mice, Knockout; Mice, Transgenic; Peptides; Prion Diseases; Prions; Recombinant Proteins | 2011 |
Advanced glycation end-products as markers of aging and longevity in the long-lived Ansell's mole-rat (Fukomys anselli).
Topics: Aging; Animals; Arginine; Biomarkers; Collagen; Female; Glycation End Products, Advanced; Longevity; Lysine; Male; Mole Rats; Skin | 2012 |
The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Female; Glycation End Products, Advanced; Heart Failure; Humans; Kaplan-Meier Estimate; Lysine; Male; Mass Spectrometry; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Severity of Illness Index; Stroke Volume | 2012 |
Maternal plasma advanced glycation end products concentrations in response to oral 50-gram glucose load in mid-pregnancy: a pilot study.
Topics: Adult; Arginine; Chromatography, High Pressure Liquid; Female; Glucose; Glucose Tolerance Test; Glycation End Products, Advanced; Humans; Hyperglycemia; Lysine; Mass Spectrometry; Pilot Projects; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Pyruvaldehyde | 2012 |
Malondialdehyde and 4-hydroxynonenal adducts are not formed on cardiac ryanodine receptor (RyR2) and sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) in diabetes.
Topics: Aldehydes; Animals; Arginine; Calcium; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Echocardiography; Guanidines; Lysine; Male; Malondialdehyde; Myocytes, Cardiac; Norleucine; Protein Carbonylation; Pyridoxamine; Pyrroles; Rats; Rats, Sprague-Dawley; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Spin Labels | 2013 |
Pentosidine determination in CSF: a potential biomarker of Alzheimer's disease?
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lysine; Male; Middle Aged; Peptide Fragments | 2014 |
Plasma advanced glycation end-products and skin autofluorescence are increased in COPD.
Topics: Aged; Arginine; Case-Control Studies; Female; Fluorescence; Glycation End Products, Advanced; Humans; Inflammation; Lung; Lysine; Male; Middle Aged; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Skin; Smoking; Spirometry | 2014 |
Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies.
Topics: Aged; Arginine; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Lysine; Male; Middle Aged | 2013 |
Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification.
Topics: Adult; Arginine; Biomarkers; C-Reactive Protein; Case-Control Studies; Chromatography, High Pressure Liquid; Coronary Artery Disease; Coronary Vessels; Diabetes Mellitus, Type 1; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Vascular Calcification; Vascular Cell Adhesion Molecule-1; von Willebrand Factor | 2013 |
Increased serum concentrations of pentosidine are related to presence and severity of coronary artery disease.
Topics: Aged; Area Under Curve; Arginine; Biomarkers; Case-Control Studies; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Cross-Sectional Studies; Female; Glycation End Products, Advanced; Humans; Logistic Models; Lysine; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Predictive Value of Tests; ROC Curve; Severity of Illness Index; Tunisia; Up-Regulation | 2014 |
Physicochemical analysis of structural alteration and advanced glycation end products generation during glycation of H2A histone by 3-deoxyglucosone.
Topics: Arginine; Chromatography, High Pressure Liquid; Circular Dichroism; Deoxyglucose; Fluorescence; Glycation End Products, Advanced; Glycosylation; Histones; Humans; Lysine; Spectroscopy, Fourier Transform Infrared | 2014 |
LC-MS/MS for the simultaneous determination of polar endogenous ADMA and CML in plasma and urine from diabetics.
Topics: Arginine; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Linear Models; Lysine; Retrospective Studies; Tandem Mass Spectrometry | 2015 |
Houttuynia cordata aqueous extract attenuated glycative and oxidative stress in heart and kidney of diabetic mice.
Topics: Animals; Arginine; Blood Glucose; Blood Urea Nitrogen; Creatine Kinase; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Fructose; Glutathione; Heart; Houttuynia; Insulin; Interleukin-6; Kidney; Lysine; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; NADPH Oxidase 2; NADPH Oxidases; NF-kappa B; Oxidative Stress; Plant Extracts; Plant Leaves; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Tumor Necrosis Factor-alpha | 2016 |
Two new prenylflavonoids from Epimedii Herba and their inhibitory effects on advanced glycation end-products.
Topics: Animals; Arginine; Diabetes Complications; Drugs, Chinese Herbal; Epimedium; Flavonoids; Glycation End Products, Advanced; Lysine; Male; Phytotherapy; Plant Components, Aerial; Prenylation; Rats | 2016 |
ADMA: a specific biomarker for pathologic progress in diabetic microvascular complications?
Topics: Adult; Aged; Area Under Curve; Arginine; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Logistic Models; Lysine; Male; Middle Aged; Odds Ratio; Prediabetic State; ROC Curve; Tandem Mass Spectrometry | 2016 |
Eucommia ulmoides extracts prevent the formation of advanced glycation end products.
Topics: Arginine; Eucommiaceae; Flavonoids; Fructose; Galactose; Gelatin; Glucose; Glycation End Products, Advanced; Glycosides; Lysine; Mannose; Plant Extracts; Ribose; Tandem Mass Spectrometry | 2016 |
Serum advanced glycation endproducts are associated with left ventricular dysfunction in normal glucose metabolism but not in type 2 diabetes: The Hoorn Study.
Topics: Aged; Arginine; Biomarkers; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Echocardiography; Female; Glycation End Products, Advanced; Humans; Linear Models; Lysine; Male; Middle Aged; Myocardial Contraction; Netherlands; Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2016 |
The effects of n-3 long-chain polyunsaturated fatty acid supplementation on AGEs and sRAGE in type 2 diabetes mellitus.
Topics: Aged; Animals; Arginine; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Dietary Supplements; Fasting; Fatty Acids, Omega-3; Female; Gene Expression Regulation; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Lysine; Male; Middle Aged; NF-kappa B; Receptor for Advanced Glycation End Products; Signal Transduction; Waist Circumference | 2016 |
Advanced Glycation End-Products Enhance Lung Cancer Cell Invasion and Migration.
Topics: Arginine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Fibronectins; Glycation End Products, Advanced; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Lung Neoplasms; Lysine; Matrix Metalloproteinase 2; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2016 |
Simultaneous Quantitation of Advanced Glycation End Products in Soy Sauce and Beer by Liquid Chromatography-Tandem Mass Spectrometry without Ion-Pair Reagents and Derivatization.
Topics: Arginine; Beer; Chromatography, Liquid; Food Analysis; Glycation End Products, Advanced; Heating; Imidazoles; Lysine; Ornithine; Reproducibility of Results; Sensitivity and Specificity; Soy Foods; Tandem Mass Spectrometry | 2016 |
Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect.
Topics: Adult; Arginine; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Lysine; Male; Metabolic Syndrome; Metformin; Middle Aged; Prognosis; Receptor for Advanced Glycation End Products | 2016 |
Immunoglobulin-G Glycation by Fructose Leads to Structural Perturbations and Drop Off in Free Lysine and Arginine Residues.
Topics: Arginine; Fructose; Glycation End Products, Advanced; Glycosylation; Humans; Immunoglobulin G; Lysine; Monosaccharides; Nitroblue Tetrazolium; Solutions; Spectrometry, Fluorescence | 2017 |
Increased serum concentrations of N
Topics: Adult; Arginine; Arthritis, Rheumatoid; Biomarkers; Case-Control Studies; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lysine; Male; Middle Aged; Severity of Illness Index | 2018 |
DAF in diabetic patients is subject to glycation/inactivation at its active site residues.
Topics: Amino Acids; Arginine; Catalytic Domain; CD55 Antigens; Complement Activation; Diabetes Mellitus; Erythrocytes; Glucose; Glycation End Products, Advanced; Humans; Lymphocyte Activation; Lysine; Models, Molecular; Ornithine; Protein Conformation; Pyrimidines; Ribose | 2018 |
Accumulation of carboxymethyl-lysine (CML) in human cortical bone.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Bone and Bones; Cell Survival; Collagen; Cortical Bone; Female; Fractures, Bone; Glycation End Products, Advanced; Humans; Hydroxyproline; Linear Models; Lysine; Male; Mass Spectrometry; Middle Aged; Risk; Young Adult | 2018 |
Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism - a source of biomarkers for clinical diagnosis.
Topics: Amino Acid Transport Systems, Basic; Arginine; Autistic Disorder; Biomarkers; Child; Female; Glycation End Products, Advanced; Humans; Lysine; Machine Learning; Male; Oxidative Stress; Sensitivity and Specificity; Tyrosine | 2018 |
Investigation of hallmarks of carbonyl stress and formation of end products in feline chronic kidney disease as markers of uraemic toxins.
Topics: Advanced Oxidation Protein Products; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biomarkers; Cats; Lysine; Oxidative Stress; Renal Insufficiency, Chronic; Urea | 2019 |
Skin Autofluorescence Measurement in Subclinical Atheromatous Disease: Results from the ILERVAS Project.
Topics: Arginine; Case-Control Studies; Cross-Sectional Studies; Female; Fluorescence; Follow-Up Studies; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Optical Imaging; Plaque, Atherosclerotic; Prognosis; Prospective Studies; ROC Curve; Skin | 2019 |
Exploring the role of body mass index in relationship of serum nitric oxide and advanced glycation end products in apparently healthy subjects.
Topics: Adult; Arginine; Body Mass Index; Cross-Sectional Studies; Female; Glycation End Products, Advanced; Healthy Volunteers; Humans; Lysine; Male; Middle Aged; Nitric Oxide; Young Adult | 2019 |
In vitro formation of Maillard reaction products during simulated digestion of meal-resembling systems.
Topics: Amino Acids; Arginine; Biological Availability; Carbohydrates; Digestion; Fructosamine; Fructose; Glucose; Intestines; Lysine; Maillard Reaction; Malabsorption Syndromes; Meals; Proteins; Starch; Sugars | 2019 |
Anti-Diabetic Effects of Gynura Bicolor Aqueous Extract in Mice.
Topics: Animals; Antidiuretic Agents; Arginine; Asteraceae; Blood Glucose; Diabetes Mellitus, Experimental; Glutathione; Humans; Kidney; Liver; Lysine; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Plant Extracts; Reactive Oxygen Species | 2019 |
Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arginine; Biomarkers; Cell Line; Diagnosis, Differential; Disease Progression; Extracellular Vesicles; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Mental Status and Dementia Tests; Neurons | 2019 |
Physico-chemical Changes Induced in the Serum Proteins Immunoglobulin G and Fibrinogen Mediated by Methylglyoxal.
Topics: Arginine; Benzothiazoles; Fibrinogen; Furaldehyde; Glycation End Products, Advanced; Glycosylation; Humans; Immunoglobulin G; Kinetics; Lysine; Malondialdehyde; Oxidation-Reduction; Protein Carbonylation; Pyruvaldehyde; Solutions; Spectrometry, Fluorescence | 2020 |
Topics: Animals; Arginine; Collagen Type I; Glycation End Products, Advanced; Glycosylation; Lysine; Mice | 2019 |
Dietary quality index is negatively associated with serum advanced glycation end products in healthy adults.
Topics: Adult; Arginine; Body Mass Index; Cross-Sectional Studies; Diet; Energy Intake; Female; Food; Glycation End Products, Advanced; Humans; Iran; Lysine; Male; Middle Aged; Nutrition Assessment | 2020 |
Gastrointestinal digestion of dietary advanced glycation endproducts using an in vitro model of the gastrointestinal tract (TIM-1).
Topics: Animals; Arginine; Chromatography, Liquid; Digestion; Fruit and Vegetable Juices; Gastrointestinal Tract; Glycation End Products, Advanced; Glyoxal; Hepatitis A Virus Cellular Receptor 1; Humans; Lysine; Milk; Pyruvaldehyde; Tandem Mass Spectrometry; Zingiber officinale | 2020 |
Pentosidine and carboxymethyl-lysine associate differently with prevalent osteoporotic vertebral fracture and various bone markers.
Topics: Aged; Aged, 80 and over; Arginine; Bone Density; Cohort Studies; Female; Glycation End Products, Advanced; Humans; Japan; Lumbar Vertebrae; Lysine; Middle Aged; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Postmenopause | 2020 |
Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE).
Topics: Arginine; Female; Glycation End Products, Advanced; Humans; Lupus Erythematosus, Systemic; Lysine; Middle Aged; Receptor for Advanced Glycation End Products | 2021 |